Below content

GeoPolitics Pulse

  • Middle East
    • Israel
    • Lebanon
    • Qatar
    • Saudi Arabia
    • Syria
    • Iraq
    • Iran
    • Turkey
  • Russia
    • Armenia
  • Asia
    • India
    • China
    • Taiwan
    • Singapore
    • Japan
    • North Korea
    • South Korea
  • Africa
  • Western Europe
    • European union
    • Germany
    • Italy
    • United Kingdom
    • France
  • Eastern Europe
    • Czechia
    • Slovakia
    • Poland
    • Hungary
    • Romania
    • Ukraine
  • America
  • Finance
    • Gold
    • Global Debt
    • BRICS
    • World Economic Forum
  • Technology
    • Amazon
    • Starbucks
    • Tesla
    • Nvidia
    • Instagram
    • Meta
    • Microsoft
    • Google
    • ChatGPT
    • Artificial Intelligence
    • Apple
    • Transhumanism
  • Australia

GeoPolitics Pulse

The Heartbeat of World events

  • Middle East
    • Israel
    • Lebanon
    • Qatar
    • Saudi Arabia
    • Syria
    • Iraq
    • Iran
    • Turkey
  • Russia
    • Armenia
  • Asia
    • India
    • China
    • Taiwan
    • Singapore
    • Japan
    • North Korea
    • South Korea
  • Africa
  • Western Europe
    • European union
    • Germany
    • Italy
    • United Kingdom
    • France
  • Eastern Europe
    • Czechia
    • Slovakia
    • Poland
    • Hungary
    • Romania
    • Ukraine
  • America
  • Finance
    • Gold
    • Global Debt
    • BRICS
    • World Economic Forum
  • Technology
    • Amazon
    • Starbucks
    • Tesla
    • Nvidia
    • Instagram
    • Meta
    • Microsoft
    • Google
    • ChatGPT
    • Artificial Intelligence
    • Apple
    • Transhumanism
  • Australia
  • Eastern Europe / European union / Western Europe

Leqembi®∇ (lecanemab) is the First Medicine that Slows – GlobeNewswire

by Editor · April 16, 2025

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and …Read More

Related posts:

  1. Leqembi® (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s …
  2. Alzheimer’s Association Commends United Kingdom’s Approval of Leqembi, But Condemns …
  3. Alzheimer’s Association Commends United Kingdom’s Approval of Leqembi, But Condemns …
  4. Leqembi’s UK Rollercoaster: A Yes From MHRA, A No From NICE – Pink Sheet
  5. Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union
  • Next story U.S. policy on stablecoins more dangerous than tariffs, Italian minister says – Reuters
  • Previous story Leqembi® (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s …

RSS BBC World News feed

  • At least two dead in Pennsylvania nursing home explosion
  • Brazil's Supreme Court allows Bolsonaro to leave prison for surgery
  • Trump trips, a fake video and 10 possible co-conspirators - Takeaways from new Epstein files

RSS Sky World News feed

  • Five dead in plane crash over Turkey
  • What we learned from the latest release of Epstein files
  • Bondi policeman injured in mass shooting wakes from coma

RSS Al Jazeera News feed

  • Russia-Ukraine war: List of key events, day 1,399
  • Belgium joins South Africa’s genocide case against Israel at ICJ
  • How will Syria deal with its growing security challenges?

RSS Iran News

  • Unveiling ceremony of “Adventure of Zaria” Book
  • Gaza death toll reaches 70,942 since Oct. 07
  • Security Council role under Resolution 2231 has ended: Iran

GeoPolitics Pulse © 2025. All Rights Reserved.

Powered by  - Designed with the Go Hueman Pro